Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial - Concepedia

Concepedia

Publication | Closed Access

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial

163

Citations

28

References

2007

Year

Jinlin Hou, You‐Kuan Yin, Dao-zhen Xu, Deming Tan, Junqi Niu, Xia-qiu Zhou, Yuming Wang, Yongwen He, Hong Ren, Mobin Wan,

Abstract

In Chinese patients with chronic hepatitis B, telbivudine treatment for 52 weeks provided greater antiviral and clinical efficacy than lamivudine, with less resistance.

References

	Year	Citations

Page 1